1-4 of 4
Halil-Ibrahim Aksoylar
Close
Sort by
Journal Articles

Specific PD-1 Deletion on Regulatory T Cells Leads to Enhanced Anti-Tumor Responses

Konstantinos Aliazis, Anthos Christofides, Halil-Ibrahim Aksoylar, Rushil Shah, Rinku Pal, Nikolaos Patsoukis, Vassiliki A Boussiotis
Journal: Blood
Blood (2023) 142 (Supplement 1): 2551.
https://doi.org/10.1182/blood-2023-174422
Published: 2023
Journal Articles

Pparα Ablation Suppresses T Cell Responses and Anti-Tumor Immunity By Compromising the Antigen-Presenting Properties of Tumor-Associated Macrophages

Anthos Christofides, Carol Cao, Qi Wang, Natalia M Tijaro-Ovalle, Eirini Konstantinidou, Rushil Shah, Chinmay Jani, Rinku Pal, Halil-Ibrahim Aksoylar, Nikolaos Patsoukis, Vassiliki A Boussiotis
Journal: Blood
Blood (2021) 138 (Supplement 1): 438.
https://doi.org/10.1182/blood-2021-149071
Published: 2021
Journal Articles

Myeloid-Specific SHP-2 Ablation Induces Robust Anti-Tumor Immunity That Is Not Further Enhanced By PD-1 Blockade

Anthos Christofides, MD, Natalia M Tijaro-Ovalle, MD, Halil-Ibrahim Aksoylar, PhD, Rinku Pal, MS, Abdelrahman AA Mahmoud, Laura Strauss, PhD, Nikolaos Patsoukis, PhD, Vassiliki A Boussiotis, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 25–26.
https://doi.org/10.1182/blood-2020-138975
Published: 2020
Journal Articles

The Rap1-RIAM Pathway Regulates the Expression of Integrins αEβ7(CD103) and α4β7, Which Guide T Cell Homing to Intestinal Compartments

Yavuz-Furkan Yazicioglu, Halil-Ibrahim Aksoylar, PhD, Rinku Pal, MS, Nikolaos Patsoukis, PhD, Vassiliki A Boussiotis, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 864.
https://doi.org/10.1182/blood-2018-99-119450
Published: 2018